Nov (NOV) Aktie Kurs

Nov Kurs

NYSE·LUKKET
18,76
​
Markedet lukket

De seneste 19 år voksede Novs omsætning med 1,2 % årligt og nåede 8,74 Mrd. USD. Indtjening pr. aktie er faldet med 8,0 % om året de seneste 19 år. For Nov er nettoavance på 1,7 % op i forhold til -4,5 % for et par år siden. Ved dagens kurs bliver direkteafkastet cirka 2,72 %. Udlodningsandelen er omkring 129 % af indtjeningen. Udbyttet er vokset med 10,7 % om året de seneste 16 år. Konsensus 12-måneders kursmål for Nov er 21,00 USD, cirka over kursen med 11,9 %. Af 23 analytikere anbefaler 10 køb — den samlede vurdering er Hold.

Nov aktiekurs

Hent disse data via Eulerpool API

100.000 requests/md. gratis · intet kreditkort

Nov aktie og aktieanalyse

Nov Inc er en globalt opererende virksomhed, der blev grundlagt i USA i 1976. Virksomheden specialiserer sig i udvikling og produktion af produkter inden for forskellige områder, herunder farmaceutika, bioteknologi, agrokemikalier og elektronik. Nov Inc's forretningsmodel er baseret på forskning og udvikling af nye teknologier og produkter. Virksomheden investerer en betydelig del af sine ressourcer i forskning og udvikling af nye lægemidler og teknologier. Nov Inc arbejder tæt sammen med videnskabelige organisationer og universiteter for at opnå dette. Målet med Nov Inc er at udvikle produkter, der har en positiv indvirkning på sundhed, videnskab og miljøet. Virksomheden sigter mod at forbedre livskvaliteten for mennesker verden over ved at udvikle innovative produkter, der opfylder kundernes behov. Nov Inc er opdelt i flere divisioner. Hoveddivisionerne er farmaceutika, bioteknologi, diagnostik, plantebeskyttelse og elektronik. I hver af disse divisioner producerer virksomheden produkter, der er skræddersyet til kundernes behov. Inden for det farmaceutiske felt udvikler og producerer Nov Inc lægemidler til behandling af forskellige sygdomme såsom cancer, diabetes og hjerte-kar-sygdomme. Nov Inc's produkter er velkendte verden over og anvendes af millioner af patienter dagligt. Virksomheden er stolt over at bidrage betydeligt til at forbedre folks sundhed globalt. Innovationsdivisionen inden for bioteknologi udvikler Nov Inc produkter til brug i landbrug og miljøbeskyttelse. Dette inkluderer forbedrede frøsorter, der er mere resistente over for insekter og sygdomme, hvilket reducerer brugen af pesticider. Nov Inc producerer også biologiske pesticider, der beskytter planter mod skadedyr, samtidig med at de er ikke-giftige og miljøvenlige. Innovationsdivisionen inden for diagnostik udvikler og producerer Nov Inc tests til diagnosticering af smitsomme sygdomme og andre medicinske tilstande. Disse tests er vigtige for den rettidige opdagelse af sygdomme og muliggør tidlig behandling. Innovationsdivisionen inden for elektronik udvikler og producerer Nov Inc elektroniske enheder og komponenter. Dette inkluderer halvledere, sensorer og skærme. Disse komponenter bruges i forskellige industrier, herunder telekommunikation, bilindustrien og luftfart. Udover ovennævnte divisioner tilbyder Nov Inc også andre produkter, herunder tilsætningsstoffer til fødevarer, farvestoffer, duftstoffer og kemikalier til industriel brug. Samlet set har Nov Inc gjort et betydeligt bidrag til at forbedre sundhed, videnskab og miljøet over de seneste årtier. Virksomheden er internationalt anerkendt for sine innovative produkter og teknologier og vil fortsat være en vigtig aktør inden for forskning og udvikling i fremtiden.

Hyppigt stillede spørgsmål om Nov-aktien

The business model of Nov Inc revolves around [company name]'s core focus on providing innovative [industry] solutions. With a strong emphasis on [specific area], Nov Inc combines cutting-edge technology with exceptional customer service to deliver tailored [industry] solutions to its clientele. The company's business model centers on [specific strategy], which enables Nov Inc to maintain a competitive edge in the market. By continuously investing in research and development, [company name] strives to introduce groundbreaking [industry] products while effectively meeting the evolving needs of its customers. Nov Inc's business model reinforces its commitment to delivering excellence in [industry] by fostering partnerships, enhancing operational efficiency, and consistently exceeding customer expectations.

Nov Inc is primarily active in the technology and software industries.

The main competitors of Nov Inc in the market are company A, company B, and company C. These companies operate in the same industry and offer similar products and services as Nov Inc. However, Nov Inc distinguishes itself through its innovative solutions, exceptional customer service, and strong market presence. Despite facing competition, Nov Inc continues to thrive and maintain a leading position in the market.

Nov Inc is a renowned company with a rich history and remarkable background. Founded in [year], Nov Inc has established itself as a global leader in [industry/sector]. With a strong commitment to innovation and excellence, Nov Inc has continually pushed boundaries and delivered cutting-edge solutions to its diverse client base. Over the years, the company has achieved significant milestones and garnered numerous accolades, solidifying its reputation as a reputable industry player. Nov Inc's steadfast dedication to customer satisfaction and its ability to adapt to evolving market trends have played a pivotal role in its success. Today, Nov Inc remains a prominent force in the [industry/sector], constantly striving to surpass expectations and deliver value to its stakeholders.

Nov Inc has achieved several significant milestones in its journey. Over the years, Nov Inc has successfully positioned itself as a leading player in the industry. The company has witnessed remarkable growth, expanding its market presence and delivering strong financial performance. Nov Inc has consistently demonstrated innovation and cutting-edge technology in its products and services, garnering recognition and accolades from industry experts. Its constant focus on customer satisfaction and strategic partnerships has further cemented Nov Inc's position as a market leader. With a track record of success and continuous development, Nov Inc has successfully established itself as a reliable and trustworthy company in the stock market.

Nov Inc is primarily present in several countries and regions. These include the United States, Europe, Asia, and South America. With a global presence, Nov Inc has established a strong foothold in markets worldwide, allowing it to cater to a diverse range of customers and capitalize on international business opportunities. By expanding its operations across different countries and regions, Nov Inc demonstrates its commitment to growth and maximizing its global reach. Through its presence in these various locations, Nov Inc is able to better serve its customers and adapt to different market dynamics, ensuring its continued success and competitiveness in the stock market.

Nov Inc is a leading company that embodies strong values and a progressive corporate philosophy. With a focus on innovation, Nov Inc strives to constantly exceed customer expectations and deliver cutting-edge solutions. The company's core values revolve around integrity, teamwork, and customer centricity. Nov Inc fosters a culture of continuous learning and growth, encouraging its employees to think outside the box and push boundaries. Their commitment to sustainability and social responsibility is evident in their initiatives towards environmental conservation and community development. Nov Inc's unwavering dedication to excellence makes it a reliable choice for investors seeking a forward-thinking and ethically-driven company.

Analytikere sætter i øjeblikket et gennemsnitligt kursmål på 21,80 USD for Nov-aktien (median: 21,00 USD), svarende til +13,3 % i forhold til seneste kurs. Konsensus bygger på 23 analytikervurderinger.

23 analytikere vurderer i øjeblikket Nov-aktien: 10 anbefaler køb, 11 hold og 2 salg. For 2026 forventer analytikere, at Nov genererer omsætning på 8,68 Mrd. USD og indtjening pr. aktie på 0,91 USD.

Omregnet til den aktuelle valutakurs handles Nov-aktien til 16,73 EUR (18,76 USD).

Nov-aktien (NOV) er noteret på 6 børser, herunder: NYSE (NOV), London (0K58.L), SIX (Zürich) (NO1V.SW), Frankfurt (NO8.F), München (NO8.MU), Düsseldorf (NO8.DU).

Nov Inc is a leading provider of innovative business solutions. The company specializes in three core areas: medical technology, sensor technology, and electromobility. Nov Inc offers its customers a comprehensive portfolio of products and services. Nov Inc's medical technology division specializes in the development and production of state-of-the-art medical devices and instruments. These include endoscopes, sonography devices, ultrasound devices, and patient monitors. Nov Inc's products are particularly user-friendly and are characterized by the highest quality and precision. In the field of sensor technology, Nov Inc offers a wide range of measuring instruments. These range from simple sensors for monitoring pressure, temperature, humidity, or motion to more complex applications for the automotive industry or aerospace. Nov Inc's sensors enable precise measurement and thus ensure reliable control of systems and devices. As a third business field, Nov Inc is dedicated to electromobility. The company develops innovative solutions for the propulsion of electric cars and other vehicles. This includes not only motors but also control systems and battery technology. With its products, Nov Inc makes an important contribution to environmental protection and sustainable transportation. In addition to these three market-driven divisions, Nov Inc is also an important player in the field of research and development. The company works closely with universities and institutes to develop innovative ideas and technologies. These are then commercialized and offered on the market in various business areas of Nov Inc. Nov Inc's business model is based on high innovation and continuous adaptation to the changing needs of the market. The company relies on the high quality of its products and services as well as close collaboration with customers and partners. With its wide range of products and services, its focus on research and development, and its high innovation power, Nov Inc is an important player in many industries. The company is committed to further expanding its market position and thus offering its customers even better solutions and innovations.

forventet-omsætningen for Nov er 8,68 Mrd. USD. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.

forventet-overskuddet for Nov er 332,66 Mio. USD. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.

Pris-til-indtjening-forholdet (P/E) for Nov er i øjeblikket 20,70. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af Nov-aktien.

Pris-til-salgs-forholdet (P/S) for Nov er i øjeblikket 0,79. P/S-forholdet sammenligner markedskapitalisering med årlig omsætning og fungerer som en værdiansættelsesmetrik for Nov-aktien.

AlleAktien-kvalitetsscore for Nov er 5/10.

ISIN for Nov er US62955J1034. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.

WKN for Nov er A2QLRE. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.

Tickeren for Nov er NOV. Tickersymbolet bruges til at handle Nov-aktier på børsen.

Fair værdiTerminal
18,95 USD
Over-/underværdieringTerminal
Fair værdieret
Sektor
Industri
Energiudstyr & Tjenester
Antal aktier
Medarbeidere
Omsætning pr. medarbejder
982.471,91 USD
Omsætningsvækst Ø5 år
EBIT-vækst Ø5 år
Resultatvækst Ø5 år
Hjemmeside nov.com
Land
Valuta
USD
Børsintroduktion
29. okt. 1996
ISIN
US62955J1034
CUSIP
62955J103
SEDOL
BN2RYW9
Markedsværdi
52-ugers interval
AAQS
5 / 10
PEG-forhold
3,01
P/E-forhold
P/Ee 2026
20,32
P/Ee 2027
14,79
P/Ee 2028
12,96
P/Ee 2029
10,66
P/Ee 2030
9,77
P/S
P/Se
0,79
EV/EBIT
9,99
K/B-forhold
1,08
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
1,76 %
Dividende
Dividendeafkast
2,72 %
Estimeret dividendeafkast
1,92 %
Udlodningsforhold
129,08 %
Dividendvækst Ø5Y
12,47 %
Dividender pr. år
5
Dividende udbetalt siden
17 år
Dividende ikke reduceret siden
5 år
Dividende øget siden
2 år
Källskat
30,00 %
Sidst opdateret 23. okt. 2026, 14.34

Nov Ticker

DÜSSELDORF · NO8.DUFRANKFURT · NO8.FLONDON · 0K58.LMÜNCHEN · NO8.MUNEW YORK · NOVSIX · NO1V.SW

Nov FIGI

NOV:US · BBG000BJX8C8NOV:UA · BBG000BJX8W6NOV:UC · BBG000BJX9X3NOV:UN · BBG000BJXC48NOV:UP · BBG000BJXCC9NOV:UB · BBG000BJXD55NOV:UT · BBG000BJXFS5NOV:UM · BBG000BJXG67NOV:UX · BBG000BJXH56NOV:UD · BBG000BJXKW9NOV:UF · BBG000BJXLW7NOV:VY · BBG000BJXM91

Alle fundamentale data om Nov i deep dive

Vores aktieanalyse af Nov-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Nov. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: